Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 25:13:25158414211003368.
doi: 10.1177/25158414211003368. eCollection 2021 Jan-Dec.

COVID-19 and conjunctivitis: a meta-analysis

Mashael Al-Namaeh  1
Affiliations

COVID-19 and conjunctivitis: a meta-analysis

Mashael Al-Namaeh. Ther Adv Ophthalmol. .

Abstract

COVID-19 is a disease first identified in Wuhan City, Hubei Province, China, in December 2019, causes by a SARS-COV-2 virus infection. By 27 October 2020, 43,921,473 confirmed cases were reported worldwide, with 1,166,389 COVID-19 deaths. Conjunctivitis has been reported in adults and pediatric patients with COVID-19.

Objective: The aim of this meta-analysis is to estimate the odd Ratio (ORs) of conjunctivitis in patients with COVID-19.

Methods: A systematic review and meta-analysis have been performed using the PubMed and Google Scholar literature search. The ORs of conjunctivitis in adults and pediatric patients is the outcome of this meta-analysis.

Results: There have been 1041 articles published since the outbreak in December 2019, according to the latest literature. For the meta-analysis, 20 studies with a total of 3383 participants were included. The odds ratio (ORs) of conjunctivitis was 0.01 (95% confidence interval [CI]: 0.00-0.02). No bias has been reported.

Conclusion: Conjunctivitis is the most common ocular manifestations reported in adults. This comprehensive meta-analysis quantifies the existing evidence linking conjunctivitis with COVID-19 and highlights the high percentage of heterogeneity that is shown in the current studies. Finally, it offers a single review article which includes all the current articles available for COVID-19 and conjunctivitis in adults and children.

Keywords: COVID-19; SARS-CoV-2; meta-analysis; viral conjunctivitis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Flow PRISMA chart presenting the total number of articles and the number of the included studies. Adapted from Moher and colleagues.
Figure 2.
Figure 2.
Forrest plot depicting pooled analysis.
See this image and copyright information in PMC

References

    1. Paudel S, Dangal G, Chalise A, et al.. The coronavirus pandemic: what does the evidence show? J Nepal Health Res Counc 2020; 18: 1–9. - PubMed
    1. Salducci M, La Torre G. COVID-19 emergency in the cruise’s ship: a case report of conjunctivitis. Clin Ter 2020; 171: e189–e191. - PubMed
    1. Dockery DM, Rowe SG, Murphy MA, et al.. The ocular manifestations and transmission of COVID-19: recommendations for prevention. J Emerg Med 2020; 59: 137–140. - PMC - PubMed
    1. Napoli PE, Nioi M, d’Aloja E, et al.. The ocular surface and the coronavirus disease 2019: does a dual “ocular route” exist? J Clin Med 2020; 9: 1269. - PMC - PubMed
    1. Liberati A, Altman DG, Tetzlaff J, et al.. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62: e1–e34. - PubMed

LinkOut - more resources